Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
Saved in:
| Title: | Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. |
|---|---|
| Authors: | Twelves, C.1, Scheithauer, W.2, McKendrick, J.3, Seitz, J.-F.4, Van Hazel, G.5, Wong, A.6, Díaz-Rubio, E.7, Gilberg, F.8, Cassidy, J.9 |
| Source: | Annals of Oncology. May2012, Vol. 23 Issue 5, p1190-1197. 8p. 2 Diagrams, 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
